The cellular origin of the IL‐1 response in BCG treated patients has not been defined, but Escherichia coli infections are known to trigger rapid IL‐1 responses the urinary bladder mucosa, where they may drive disease progression and pain, especially in acute cystitis and patients susceptible to bladder pain syndrome.44, 45. This evidence concerns the gene IL1B and escherichia coli infection.